Arterra Bioscience
ARBS.MI · MIL
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 33.8% | -24.9% | 136% | – |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 18.6% | 20.3% | 55% | 57.1% |
| EBITDA | €0 | €0 | €0 | €0 |
| % Margin | 47.7% | 65% | 23.2% | 112.6% |
| Net Income | €0 | €0 | €0 | €0 |
| % Margin | 42.2% | 42.6% | 20.2% | 76.3% |
| EPS Diluted | 0.16 | 0.12 | 0.078 | 0.12 |
| % Growth | 33.3% | 54.4% | -35.2% | – |
| Operating Cash Flow | €0 | €0 | €0 | €0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | €0 | -€0 | €0 | €0 |